Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Las Vegas Sands Corp.

Start price
Target price
Perf. (%)
€48.89
24.11.20
-
24.11.21
-3.86%
08.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Higher risks for its business
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€118.90
23.11.20
€125.00
5.45%
24.11.20

EBIT growth > 30% per year expected
Undervalued
Very high dividend yield expected
Top Rating
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€163.80
23.11.20
€184.00
23.11.21
29.76%
02.06.21

Could be worthwhile Investment >10% per year
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.76
23.11.20
-
23.11.21
157.64%
24.11.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Citizens Financial

Start price
Target price
Perf. (%)
€27.20
21.11.20
-
21.11.21
15.44%
22.01.21

Revenue growth >5% per year expected
EBIT decline/stagnation expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€82.11
20.11.20
-
2.28%
17.12.20

buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.60
19.11.20
€426.00
19.11.21
1.19%
23.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
DISH Network Corp. A

Start price
Target price
Perf. (%)
€28.40
18.11.20
-
18.11.21
-11.27%
27.01.21

Higher risks for its business
Very low/no dividend yield expected
Few uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
buy
A.O. Smith Corp.

Start price
Target price
Perf. (%)
€46.89
17.11.20
-
17.11.21
2.52%
23.01.21

High dividend yield expected
Future proof or reliable business model
Valuable balance sheet
Probably not worthwhile Investment
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

buy
Trane Technologies plc

Start price
Target price
Perf. (%)
€132.00
16.11.20
€150.00
16.11.21
-8.33%
28.11.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Small cyclical dependencies
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€133.58
16.11.20
-
16.11.21
0.24%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Carnival plc

Start price
Target price
Perf. (%)
€12.76
15.11.20
€28.00
15.11.21
40.91%
16.11.21

EBIT growth >5% per year expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Bad rating
buy
American Water Works Corp. Inc.

Start price
Target price
Perf. (%)
€138.12
14.11.20
€155.00
14.11.21
10.30%
06.08.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Kimco Realty

Start price
Target price
Perf. (%)
€12.88
14.11.20
-
14.11.21
-3.15%
27.11.20

High valuation
Higher risks for its business
Significant cyclical dependencies
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.30
14.11.20
-
14.11.21
-1.75%
23.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Qualcomm Inc.

Start price
Target price
Perf. (%)
€123.48
14.11.20
€150.00
14.05.21
-14.32%
14.05.21

buy
Verisk Analytics A

Start price
Target price
Perf. (%)
€174.02
13.11.20
-
13.11.21
-9.85%
13.02.21

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very low/no dividend yield expected